Text Size
278 studies found for:    Emphysema: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed
Has Results 		Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Pulmonary Emphysema
Interventions: Drug: Stem cells stimulation;   Procedure: stem cells collection;   Genetic: stem cells infusion
22 Recruiting A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema
Conditions: Chronic Pulmonary Obstructive Disease;   Emphysema
Intervention:
23 Completed Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
Conditions: Pulmonary Emphysema;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: Biologic Lung Volume Reduction (BLVR) - 10 mL Hydrogel
24 Completed US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
Condition: Pulmonary Emphysema
Intervention: Drug: BLVR System
25 Recruiting Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: tetomilast;   Drug: placebo
26 Terminated Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Hydrogel
27 Terminated Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Hydrogel
28 Completed US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR
29 Withdrawn Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema
Condition: Advanced Upper Lobe Predominant Emphysema
Intervention: Drug: BLVR
30 Completed Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)
Condition: Heterogeneous Emphysema
Intervention: Device: Chartis System
31 Completed Endobronchial Valve for Emphysema Palliation Trial (VENT)
Conditions: Chronic Obstructive Pulmonary Disease;   Emphysema
Intervention: Procedure: Emphasys Endobronchial Valve and procedure
32 Completed Evaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Subjects With Homogeneous Emphysema
Condition: Emphysema
Intervention: Device: Lung Volume Reduction Coil (LVRC) (PneumRx, Inc.)
33 Completed
Has Results 		Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Chronic Obstructive Pulmonary Disease;   Bronchitis;   Emphysema
Interventions: Drug: Arformoterol Tartrate Inhalation Solution;   Drug: Tiotropium;   Drug: Arformoterol and Tiotropium;   Drug: Placebo
34 Active, not recruiting International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema
Condition: Emphysema
Interventions: Biological: Kamada AAT for inhalation;   Other: Placebo
35 Active, not recruiting Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease (COPD);   Cystic Fibrosis;   Pulmonary Fibrosis;   Bronchiectasis;   Sarcoidosis;   Pulmonary Hypertension;   Alpha-1 Antitrypsin Deficiency
Interventions: Procedure: Transplantation of Lungs After Ex-vivo Perfusion w/ STEEN Solution™;   Device: Steen Solution™
36 Completed Feasibility Study of PneumRx's Lung Volume Reduction Coil (LVRC)
Condition: Emphysema
Intervention: Device: Lung Volume Reduction Coil (LVRC) (PneumRx's)
37 Completed Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)
Condition: Alpha 1-Antitrypsin Deficiency
Interventions: Drug: Alpha1-Proteinase Inhibitor (Human);   Drug: Albumin (Human) 20%, USP
38 Completed Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema
Conditions: Pulmonary Fibrosis;   Emphysema
Intervention:
39 Recruiting Bronchoscopic Intrabullous Autologous Blood Instillation (BIABI) for Emphysema
Condition: Bullous Emphysema
Intervention: Procedure: Bronchoscopic intrabullous autologous blood instillation
40 Recruiting Post Market Registry Study of the AeriSeal System
Condition: Pulmonary Emphysema
Intervention:
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years